The National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, has awarded a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract to acquire Genome Characterization Center (GCC) services. The contract, valued at up to $149,974,285, has a period of performance through January 2030. The GCC services include large-scale, high-resolution, and comprehensive sequencing and array platforms, such as whole exome sequencing, to support...
This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. Department of Health and Human Services, to The Washington University's Office of Sponsored Research Services Division. The contract is for Genome Characterization Center (GCC) services, which involve large-scale, high-resolution, and comprehensive sequencing and array platforms, including whole exome sequencing. The purpose is to perform genomic characterization of cancer...
This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian federal agency, to Infinity Biologix LLC, doing business as Sampled Division, to acquire genome characterization center (GCC) services consisting of large-scale, high-resolution, and comprehensive sequencing and array platforms, including whole exome sequencing. The contract has a ceiling value of $149,974,285 and a period of performance through January 2030. The contract aims to support...
The National Cancer Institute (NCI) awarded an Indefinite Delivery Contract (IDC), Contract No. 75N91025D00009, to the University of Southern California (USC) to provide Genome Characterization Center (GCC) services. The purpose of this multiple-award IDC is to acquire comprehensive sequencing and array platforms, including whole exome sequencing, to support NCI's cancer genomics research programs. The GCCs will receive biomaterials from a centralized Biospecimen Processing Center and perform...
The National Cancer Institute (NCI) has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract, valued up to $149,974,285, to the University of North Carolina at Chapel Hill (UNC-CH) to provide Genome Characterization Center (GCC) services. The contract aims to acquire comprehensive genome sequencing and analysis capabilities to support NCI's cancer genomics research programs. The GCC services include whole exome sequencing, transcriptomics, and epigenomic characterization of...
The National Cancer Institute (NCI), part of the National Institutes of Health within the Department of Health and Human Services, has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Azenta US Inc., doing business as Brooks Life Sciences Inc., for the provision of genomic characterization services to support the NCI's Center for Cancer Genomics research programs. The IDIQ contract has a $49,832,452 ceiling value and a period of performance from August 31, 2019 through...
This Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) National Cancer Institute (NCI) to The Broad Institute, Inc., a non-profit biomedical and genomic research organization. The $49.8 million IDC supports the NCI Genomic Characterization Centers and provides comprehensive genomic sequencing, data analysis, and other advanced computational biology services to NCI institutes and centers. Under the IDC, The Broad Institute has been awarded multiple task...
This single award Indefinite Delivery Contract (IDC) was awarded by the Office of Acquisitions and Grants, a civilian federal agency, to Genewiz, LLC, a for-profit limited liability company. The 5-year, $150,000 contract (awarded on April 1, 2025) provides an IDIQ vehicle for RNA extraction and sequencing services to support the agency's research initiatives. Genewiz, a global contract research organization specializing in genomic services, will deliver a range of molecular biology and...
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to The GOG Foundation, Inc., a non-profit organization that provides administrative and operational support for cancer research programs. The $123,496.76 contract is part of the NCI Cancer Genome Atlas Program and involves the collection of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The GOG Foundation, Inc. will likely leverage its expertise in...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The contract, valued at $200,000, supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The initial $120,500 task order under this contract requires the...
The federal contract IDV award is for Genome Characterization Center (GCC) services consisting of large-scale, high-resolution, and comprehensive sequencing and array platforms to support the National Cancer Institute's (NCI) Center for Cancer Genomics (CCG) program. The $149,974,285 multiple-award IDIQ contract was awarded to the New York Genome Center, Inc. (NYGC), a non-profit academic research institution, with a period of performance running through January 2030.
The GCC services will receive and process biospecimens from cancer patients to perform high-throughput DNA sequencing, RNA sequencing, epigenetic characterization, and single-cell/nucleus sequencing. The data generated will be deposited into the NCI Genomic Data Commons to facilitate cancer genomics research. The contract does not have any set-asides, reflecting the specialized nature of the genomic sequencing and analysis services. The original solicitation was a small business sources sought notice to identify qualified small businesses across four functional pools to potentially compete for the IDIQ contract.